Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
List of Prohibited Medicines - The Pharma Times | Pharma & Health Care News Portal
Categories: Press Release

List of Prohibited Medicines

New Delhi, August 17, 2013: A drug banned / restricted in one country may continue to be marketed in other countries as the respective governments examine the usage, doses, indications permitted etc. and overall risk benefits ratio and take decisions on the continued marketing of any drug in these countries.

Safety issues of drug formulations, as and when reported, are assessed in consultation with the Expert Committees / Drugs Technical Advisory Board (DTAB). Based on the recommendations of the Expert Committees / DTAB, the Central Government prohibits manufacture, sale and distribution of such drugs in the country through Gazette Notification.

The Central Government has prohibited / suspended manufacture, sale and distribution of following drugs during the last three years and in the current year in the country through Notifications in the Gazette of India:

1.      Rosiglitazone.

2.      Nimesulide formulations in children below 12 years of age.

3.      Cisapride and its formulations for human use.

4.      Phenylpropanolamine and its formulations for human use.

5.      Human Placental Extract and its formulations for human use except its

(i)  Topical application for wound healing, and

(ii) Injection for pelvic inflammatory disease.

6.      Sibutramine and its formulations for human use.

7.      R-Sibutramine and its formulations for human use.

8.      Gatifloxacin formulation for systemic use in human by any route including oral and injectable

9.      Tegaserod and its formulations

10.  Letrozole for induction of ovulation in anovulatory infertility.

11.  Serodiagnostic test kits for diagnosis of tuberculosis

12.  Dextropropoxyphene and formulations containing Dextropropoxyphene for human use.

13.  Fixed dose combination of Flupenthixol + Melitracen for human use

14.  Analgin and all formulations containing analgin for human use.

 

This information was given by Union Minister of Health & Family Welfare Shri Ghulam Nabi Azad, in written reply to a question in the Rajya Sabha today. — CCI Newswire

The Pharma Times News Bureau

Recent Posts

Gleneagles Hospital Mumbai Introduces Pediatric Bone Marrow Transplant (BMT) Facility

New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…

22 hours ago

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

2 days ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

3 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

4 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

7 days ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

1 week ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420